NZ activist group calls for DTC ban

Share this article:
A New Zealand activist group joined the anti-DTC advertising pile-on, urging its ouster by the end of 2006.

The Public Health Association, a non-party voluntary political association, said consumer drug ads prompt patients to pressure doctors and “normalize” the use of medicine to resolve issues.

“People may end up paying for medicines that they don't need and that, in the worst case scenario, may actually be harmful to them,” said the group's director, Dr. Gay Keating.

The National Party countered that a ban would inhibit drug research.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...